The Interplay between Immune System and Microbiota in Osteoporosis

Area of Science:

• Bone Biology and Metabolism
• Microbiome Research
• Immunology

Background:

• Osteoporosis is characterized by low bone mass and microarchitectural changes, increasing fracture risk.
• Current osteoporosis treatments face safety and tolerance issues with long-term use.
• The gut microbiota's influence on bone metabolism is a recent area of research.

Purpose of the Study:

• To explore the role of gut microbiota in bone metabolism and its potential as a therapeutic target for osteoporosis.
• To review the mechanisms by which gut microbiota influences bone mineral density.
• To assess the current evidence for prebiotics and probiotics in managing bone health.

Main Methods:

• Review of existing literature on gut microbiota, immune system, and bone cell interactions.
• Analysis of studies using germ-free mouse models to understand microbiota-host interactions.
• Examination of research on prebiotics and probiotics and their effects on bone metabolism.

Main Results:

• Gut microbiota influences calcium and vitamin D absorption, gut permeability, hormonal secretion, and immune responses.
• Key pathways involved include T helper 17 lymphocytes, TNF, IL-17, RANK ligand, NOD1, NOD2, and TLR5.
• Evidence in animal models suggests microbiota manipulation impacts bone density, but human data is limited and controversial.

Conclusions:

• Gut microbiota manipulation is a potential strategy for preventing and treating osteoporosis and other bone alterations.
• Further clinical studies are essential to establish effective human protocols for microbiota-based interventions.
• Understanding the complex interactions between microbiota, immunity, and bone is crucial for future therapeutic development.